4.7 Article

Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma

Journal

JOURNAL OF TRANSLATIONAL MEDICINE
Volume 12, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/1479-5876-12-190

Keywords

Hepatocellular carcinoma; Soluble CD147; Matrix metalloproteinases; Alpha-fetoprotein; Serological marker

Funding

  1. National Natural Science Foundation of China [81172144]
  2. National Science and Technology Major Project [2012ZX10002-015, 2012AA020806]

Ask authors/readers for more resources

Background: As a surface glycoprotein, CD147 is capable of stimulating the production of matrix metalloproteinases (MMPs) from neighboring fibroblasts. The aim of the present study is to explore the role of soluble CD147 on MMPs secretion from hepatocellular carcinoma (HCC) cells, and to investigate the diagnostic value of serum soluble CD147 in the HCC detection. Methods: We identified the form of soluble CD147 in cell culture supernate of HCC cells and serum of patients with HCC, and explored the role of soluble CD147 on MMPs secretion. Serum CD147 levels were detected by the enzyme-linked immunosorbent assay, and the value of soluble CD147 as a marker in HCC detection was analyzed. Results: Full length soluble CD147 was presented in the culture medium of HCC cells and serum of patients with HCC. The extracellular domain of soluble CD147 promoted the expression of CD147 and MMP-2 from HCC cells. Knockdown of CD147 markedly diminished the up-regulation of CD147 and MMP-2 which induced by soluble CD147. Soluble CD147 activated ERK, FAK, and PI3K/Akt pathways, leading to the up-regulation of MMP-2. The level of soluble CD147 in serum of patients with HCC was significantly elevated compared with healthy individuals (P < 0.001). Soluble CD147 levels were found to be associated with HCC tumor size (P = 0.007) and Child-Pugh grade (P = 0.007). Moreover, soluble CD147 showed a better performance in distinguishing HCC compared with alpha-fetoprotein. Conclusions: The extracellular domain of soluble CD147 enhances the secretion of MMP-2 from HCC cells, requiring the cooperation of membrane CD147 and activation of ERK, FAK, and PI3K/Akt signaling. The measurement of soluble CD147 may offer a useful approach in diagnosis of HCC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Oncology

Metabolic checkpoints and novel approaches for immunotherapy against cancer

Yiming Li, Juan Tang, Jianli Jiang, Zhinan Chen

Summary: Immunotherapy has achieved significant success in treating cancer, but resistance to this treatment often occurs due to the complex metabolic networks in the tumor microenvironment. Metabolic checkpoints play a crucial role in regulating T cell development, differentiation, and function, as well as coordinating metabolic competition between tumor cells and infiltrating T cells. Thus, targeting metabolic checkpoints may enhance the efficacy of immunotherapy.

INTERNATIONAL JOURNAL OF CANCER (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Hepatic Artery Injection of 131I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial

Hui Chen, Gang Nan, Ding Wei, Ren-You Zhai, Ming Huang, Wu-Wei Yang, Bao-Cai Xing, Xu Zhu, Hai-Feng Xu, Xiao-Dong Wang, Xiao-Yong Zhang, Bao-Rang Zhu, Peng Liu, Guang Cao, Song Gao, Chun-Yi Hao, Ren-Jie Yang, Jian-Hai Guo, Xin Zhang, Kun Gao, Kun Wang, Jian-Feng Wang, Zi-Yu Li, Lin-Zhong Zhu, Rong Ding, Jing Li, Ling Zhao, Yu-Jun Shao, Hai-Chun Liu, Jie-Lai Xia, Ling Wang, Ling-Min Kong, Zhi-Nan Chen, Huijie Bian

Summary: In the adjuvant treatment of unresectable hepatocellular carcinoma, the combination of TACE and I-131-MabThera showed superior antirecurrence efficacy, significantly improved 5-year survival rate of patients, and was well tolerated.

JOURNAL OF NUCLEAR MEDICINE (2022)

Editorial Material Cell Biology

New avenues for NASH therapy by targeting ACC

Huijie Bian, Ye-Mao Liu, Zhi-Nan Chen

Summary: Two recent studies have found new strategies for ACC targeting in NASH therapy, successfully resolving the unwanted side effects of ACC inhibitors and bringing new hope to NASH treatment.

CELL METABOLISM (2022)

Article Oncology

MyD88 in myofibroblasts regulates aerobic glycolysis-driven hepatocarcinogenesis via ERK-dependent PKM2 nuclear relocalization and activation

Qi Yuan, Jie Zhang, Yu Liu, Haiqiang Chen, Haiyang Liu, Jinyan Wang, Meng Niu, Lingling Hou, Zhenlong Wu, Zhinan Chen, Jinhua Zhang

Summary: MyD88 in myofibroblasts plays a critical role in promoting hepatocellular carcinoma by affecting aerobic glycolysis in cancer cells. MyD88 deficiency in myofibroblasts attenuates liver fibrosis and liver cancer tissue. Mechanistically, MyD88 signaling in myofibroblasts increases the secretion of CCL20, which promotes aerobic glycolysis in cancer cells. This process is dependent on the CCR6 receptor and ERK/PKM2 signaling.

JOURNAL OF PATHOLOGY (2022)

Article Biochemistry & Molecular Biology

CD147 supports paclitaxel resistance via interacting with RanBP1

Gang Nan, Shu-Hua Zhao, Ting Wang, Dong Chao, Ruo-Fei Tian, Wen-Jing Wang, Xin Fu, Peng Lin, Ting Guo, Bin Wang, Xiu-Xuan Sun, Xi Chen, Zhi-Nan Chen, Shi-Jie Wang, Hong-Yong Cui

Summary: This study investigates the role and mechanisms of CD147 in paclitaxel resistance. It demonstrates that CD147 protects cancer cells from paclitaxel-induced apoptosis and interacts with the C-terminal tail of RanBP1 to regulate microtubule stability and dynamics as well as response to paclitaxel treatment. Targeting CD147 may be a potential strategy for preventing paclitaxel resistance.

ONCOGENE (2022)

Article Biochemistry & Molecular Biology

Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis

Cheng-Gong Liao, Xiao-Hua Liang, Yuan Ke, Li Yao, Man Liu, Ze-Kun Liu, Lin He, Yi-Xiao Guo, Huijie Bian, Zhi-Nan Chen, Ling-Min Kong

Summary: This study reveals that active demethylation of CD147 is involved in the metastasis of non-small cell lung cancer (NSCLC), and targeted methylation of CD147 can inhibit the invasion and metastasis of NSCLC, providing a promising therapeutic target for NSCLC.

ONCOGENE (2022)

Article Oncology

Chimeric antigen receptor T cells targeting CD147 for non-small cell lung cancer therapy

Xiao-Hong Chen, Ruo Chen, Ming-Yan Shi, Ruo-Fei Tian, Hai Zhang, Zhi-Qian Xin, Zhi-Nan Chen, Ke Wang

Summary: This study evaluated the significant role of CD147 in NSCLC through bioinformatics analysis and confirmed the efficacy and safety of CD147-CART cells in treating NSCLC through experiments.

TRANSLATIONAL ONCOLOGY (2022)

Article Multidisciplinary Sciences

TNF antagonist sensitizes synovial fibroblasts to ferroptotic cell death in collagen-induced arthritis mouse models

Jiao Wu, Zhuan Feng, Liang Chen, Yong Li, Huijie Bian, Jiejie Geng, Zhao-Hui Zheng, Xianghui Fu, Zhuo Pei, Yifei Qin, Liu Yang, Yilin Zhao, Ke Wang, Ruo Chen, Qian He, Gang Nan, Xuejun Jiang, Zhi-Nan Chen, Ping Zhu

Summary: In this study, the authors use a mouse model of rheumatoid arthritis (RA) and single-cell RNA sequencing to show that inducing ferroptosis and suppressing TNF signaling can reduce the number of fibroblasts in the synovium and improve experimental arthritis. They further identify two groups of fibroblasts with distinct susceptibility to ferroptosis and show that TNF signaling protects fibroblasts from ferroptosis through promoting cystine uptake and glutathione biosynthesis. Finally, the combination of low-dose ferroptosis inducer and TNF antagonist attenuates arthritis progression in the mouse model.

NATURE COMMUNICATIONS (2022)

Article Immunology

Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer

Ming Zheng, Yi-Ming Li, Zhen-Yu Liu, Xin Zhang, Yinghui Zhou, Jian-Li Jiang, Ping Zhu, Xiang-Min Yang, Juan Tang, Zhi-Nan Chen

Summary: Immunotherapy targeting tumor-infiltrating lymphocytes has shown promising potential as a treatment for various cancers, but its efficacy varies across different cancer types and patients. The distribution of TIL-T and TIL-B cells and their interactions with the tumor microenvironment play a crucial role in determining the clinical outcomes. Understanding the prognostic significance of these factors can have important implications for cancer immunotherapy.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute lymphoblastic leukemia

Nai-Shan Zheng, Xiang-Yu Zhao, Ding Wei, Jin-Lin Miao, Ze-Kun Liu, Yu-Le Yong, Ren-Yu Zhang, Yi-Xiao Guo, Lin He, Bin Wang, Xiu-Xuan Sun, Hai-Jiao Yang, Tian-Jiao Zhang, Qian He, Xiao-Min Li, Hai Zhang, Rong Hou, Peng Lin, Ying-Ming Xu, Xiao-Jun Huang, Zhi-Nan Chen, Huijie Bian

Summary: CD147-CAR T cell therapy shows potent anti-tumor activity against T cell acute lymphoblastic leukemia (T-ALL) and potential safety towards normal cells and CD147-deficient cells.

CANCER LETTERS (2022)

Article Immunology

SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in an Arf6-dependent manner

Yun-Qi Zhou, Ke Wang, Xue-Yan Wang, Hong-Yong Cui, Yongxiang Zhao, Ping Zhu, Zhi-Nan Chen

Summary: This study reveals that SARS-CoV-2 enters host cells through CD147-mediated endocytosis, highlighting the potential of blocking this pathway as a preventive approach against SARS-CoV-2 infection.

EMERGING MICROBES & INFECTIONS (2022)

Article Oncology

Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma

Ze-Kun Liu, Ke-Fei Wu, Ren-Yu Zhang, Ling-Min Kong, Run-Ze Shang, Jian-Jun Lv, Can Li, Meng Lu, Yu-Le Yong, Cong Zhang, Nai-Shan Zheng, Yan-Hong Li, Zhi-Nan Chen, Huijie Bian, Ding Wei

Summary: In this study, a prognostic signature based on pyroptosis-related lncRNAs in hepatocellular carcinoma (HCC) was constructed, showing significant predictive value for HCC patient prognosis and potential clinical guidance for individualized immunotherapy.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

PDGFA-associated protein 1 is a novel target of c-Myc and contributes to colorectal cancer initiation and progression

Hong-Yong Cui, Wei Wei, Mei-Rui Qian, Ruo-Fei Tian, Xin Fu, Hong-Wei Li, Gang Nan, Ting Yang, Peng Lin, Xi Chen, Yu-Meng Zhu, Bin Wang, Xiu-Xuan Sun, Jian-Hua Dou, Jian-Li Jiang, Ling Li, Shi-Jie Wang, Zhi-Nan Chen

Summary: This study identified PDAP1 as a key player in colorectal cancer (CRC) development. PDAP1 overexpression was associated with cell proliferation, migration, invasion, and metastasis in CRC. Inhibiting PDAP1 may be an effective strategy for treating CRC patients with PDAP1 overexpression.

CANCER COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development

Ren-Yu Zhang, Ze-Kun Liu, Ding Wei, Yu-Le Yong, Peng Lin, Hao Li, Man Liu, Nai-Shan Zheng, Ke Liu, Cai-Xia Hu, Xiao-Zhen Yang, Zhi-Nan Chen, Huijie Bian

Summary: The study identified two novel somatic mutations of UBE2S in HCC, with potential deleterious effects, and found that wild-type UBE2S was significantly upregulated in HCC tissues, closely related to clinicopathological features. Functional assays demonstrated that UBE2S overexpression promoted proliferation and invasion of HCC cells, with interaction with TRIM28 facilitating cell cycle progression. Importantly, the small molecule cephalomannine was shown to inhibit UBE2S expression and attenuate HCC progression, suggesting a promising therapeutic strategy.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Immunology

CD147 regulates antitumor CD8+ T-cell responses to facilitate tumor-immune escape

Yatong Chen, Jing Xu, Xiaodong Wu, Hui Yao, Zhou Yan, Ting Guo, Wenjing Wang, Peixiao Wang, Yu Li, Xiangmin Yang, Hao Li, Huijie Bian, Zhi-Nan Chen

Summary: Deletion of CD147 in T cells limits tumor growth in mouse melanoma and lung cancer. CD147 is upregulated in CD8(+) TILs and coexpressed with immune-checkpoint molecules, leading to increased antitumor responses and potential as a target for cancer immunotherapy.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

No Data Available